Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

31.94
-0.0700-0.22%
Post-market: 32.290.3500+1.10%18:07 EDT
Volume:3.61M
Turnover:117.32M
Market Cap:3.59B
PE:-27.69
High:33.61
Open:32.56
Low:31.81
Close:32.01
Loading ...

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Quartz
·
14 Mar

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Zacks
·
14 Mar

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks
·
13 Mar

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Zacks
·
13 Mar

B. Riley sees two key positives in Viking manufacturing agreement

TIPRANKS
·
11 Mar

Viking Therapeutics closer to bringing its Ozempic competitor to market

Quartz
·
11 Mar

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

Viking supply pact may hurt takeover prospects, says William Blair

TIPRANKS
·
11 Mar

Cordenpharma, Viking Therapeutics form long-term partnership to provide key materials to make injectable and oral medications

Reuters
·
11 Mar

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Blockhead
·
11 Mar

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

Zacks
·
11 Mar

Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

Zacks
·
11 Mar

Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program

MT Newswires Live
·
11 Mar

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

PR Newswire
·
11 Mar

H.C. Wainwright says Novo results support Viking obesity potential

TIPRANKS
·
10 Mar

Promising Potential of Viking Therapeutics’ VK2735 in Obesity and Diabetes Treatment Drives Buy Rating

TIPRANKS
·
10 Mar

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Zacks
·
08 Mar

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
08 Mar

Analysts’ Top Healthcare Picks: Editas Medicine (EDIT), Viking Therapeutics (VKTX)

TIPRANKS
·
07 Mar

Viking Therapeutics: Promising Obesity Pipeline and Strategic Growth Catalysts Justify Buy Rating

TIPRANKS
·
06 Mar